563 related articles for article (PubMed ID: 19646137)
1. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
[No Abstract] [Full Text] [Related]
2. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
Strober BE; Clarke S
J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.
Caproni M; Antiga E; Melani L; Volpi W; Del Bianco E; Fabbri P
J Clin Immunol; 2009 Mar; 29(2):210-4. PubMed ID: 18763027
[TBL] [Abstract][Full Text] [Related]
4. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
5. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
Nikkels AF; Piérard GE
J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
[No Abstract] [Full Text] [Related]
6. ILVEN: is it psoriasis? Debate based on successful treatment with etanercept.
Renner R; Colsman A; Sticherling M
Acta Derm Venereol; 2008; 88(6):631-2. PubMed ID: 19002357
[No Abstract] [Full Text] [Related]
7. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
[TBL] [Abstract][Full Text] [Related]
8. Acitretin narrow-band TL-01 phototherapy but not etanercept treatment improves a localized inflammatory linear verrucous epidermal naevus with concomitant psoriasis.
Ozdemir M; Mevlitoğlu I; Balevi A
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1453-4. PubMed ID: 19470068
[No Abstract] [Full Text] [Related]
9. Childhood psoriasis: often favorable outcome.
Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
[TBL] [Abstract][Full Text] [Related]
10. Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.
Thayer S; Watson C; Song R; Globe DR; Harrison DJ
J Med Econ; 2010; 13(2):228-35. PubMed ID: 20459298
[TBL] [Abstract][Full Text] [Related]
11. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
[No Abstract] [Full Text] [Related]
12. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
Lee JH; Youn JI; Kim TY; Choi JH; Park CJ; Choe YB; Song HJ; Kim NI; Kim KJ; Lee JH; Yoo HJ
BMC Dermatol; 2016 Jul; 16(1):11. PubMed ID: 27455955
[TBL] [Abstract][Full Text] [Related]
13. Etanercept for the treatment of psoriasis.
Bissonnette R
Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
[TBL] [Abstract][Full Text] [Related]
14. Superimposed linear psoriasis: low effectiveness of biologic therapy.
Colombo L; Marconi M; Mapelli ET; Crespi E; Gualandri L; Menni S; Cerri A
G Ital Dermatol Venereol; 2011 Aug; 146(4):311-3. PubMed ID: 21785401
[No Abstract] [Full Text] [Related]
15. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
Yamauchi PS; Lowe NJ
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
[No Abstract] [Full Text] [Related]
16. Recalcitrant palmoplantar pustular psoriasis treated with etanercept.
Floristan U; Feltes R; Ramírez P; Alonso ML; De Lucas R
Pediatr Dermatol; 2011; 28(3):349-50. PubMed ID: 21371112
[TBL] [Abstract][Full Text] [Related]
17. Adolescent plaque psoriasis: our experience using etanercept.
Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
[No Abstract] [Full Text] [Related]
18. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
19. Etanercept for the treatment of severe childhood psoriasis.
Papoutsaki M; Costanzo A; Mazzotta A; Gramiccia T; Soda R; Chimenti S
Br J Dermatol; 2006 Jan; 154(1):181-3. PubMed ID: 16403117
[No Abstract] [Full Text] [Related]
20. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
